A Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Assess Cognitive Effects of Cognitive Nutritional Supplementation in the General Population
Pharmavite LLC
Summary
This is a double-blind, randomized, 12-week parallel study that aims to determine the effects of a cognitive nutritional supplement for 12 weeks on cognition parameters specific to attention/focus related domains, compared to a placebo control, in a general population of adult men and women in the United States.
Eligibility
- Age range
- 25–65 years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: 1. Male or female, ≥25 to ≤65 years of age at screening. 2. English is the primary spoken language. 3. Able to operate a study-provided iPad connected to the internet with a strong and reliable internet connection. 4. Willing to consume 3 capsules per day for 12 weeks. 5. Willing to review and follow all training materials provided. 6. Willing to avoid alcohol, marijuana/hemp products (including CBD products), and vigorous physical activity 24 h prior to the baseline (week 0), mid-point (Week 6), and end of study (Week 12) cognition testing days. 7. Non-user or former user…
Interventions
- Dietary SupplementCognitive Nutritional Supplement
Pills of cognitive nutritional supplement
- OtherPlacebo
Matching placebo to active
Location
- Biofortis Innovation ServicesAddison, Illinois